Resumen de Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain

Manuel Hidalgo Medina, Alberto Carmona Bayonas, R. Álvarez Gallego, Javier Gallego Plazas, Berta Laquente Sáez, T. Macarulla, Andrés Jesús Muñoz Martín, Mercedes Salgado Fernández, Ruth Vera García, J. Adeva, Carmen Guillén Ponce, Javier Blázquez Sánchez, Sara Arévalo Lobera, Agnès Calsina-Berna, I. Ales Díaz

• The management of patients with pancreatic cancer has advanced over the last few years. We convey a multidisciplinary group of experts in an attempt to stablish practical guidelines for the diagnoses, staging and management of these patients. This paper summarizes the main conclusions of the working group. Patients with suspected pancreatic ductal adenocarcinoma should be rapidly evaluated and referred to high-volume centers. Multidisciplinary supervision is critical for proper diagnoses, staging and to frame a treatment plan. Surgical resection together with chemotherapy offers the highest chance for cure in early stage disease. Patients with advanced disease should be classified in treatment groups to guide systemic treatment. New chemotherapeutic regimens have resulted in improved survival. Symptomatic management is critical in this disease. Enrollment in a clinical trial is, in general, recommended.